Highly rated in
Highly rated in
Check Dr. Philip E. Schaner's experience treating your condition:
About Dr. Philip E. Schaner

Philip Schaner is a Radiation Oncologist and an Occupational Medicine expert in Lebanon, New Hampshire. Schaner has been practicing medicine for over 17 years and is highly rated in 21 conditions, according to our data. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer SCLC. He is licensed to treat patients in New Hampshire. Schaner is currently accepting new patients.

His clinical research consists of co-authoring 25 peer reviewed articles and participating in 7 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Philip E. Schaner it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Philip E. Schaner accepts the following insurance:

  •  Ambetter
  •  Anthem

Call to see if your plan is accepted.
1 Medical Center Dr, Lebanon, NH 03756
Background & Education
Graduate Institution
University Of Michigan Medical School, 2005
Radiation Oncology
Occupational Medicine
Undersea and Hyperbaric Medicine in NH
Hospital Affiliations
White River Junction VA Medical Center
Brattleboro Memorial Hospital
Dartmouth-Hitchcock Medical Center
North Country Hospital And Health Center
Cheshire Medical Center
Speare Memorial Hospital
Littleton Regional Healthcare
Northeastern Vermont Regional Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Tumor Oximetry Using Electron Paramagnetic Resonance (EPR) With India Ink (Using Carbon Particulates From Carlo Erba [CE])
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
View 4 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors